Boston Scientific (BSX) Reports In-Line Q2 EPS; Bumps FY16 Rev View
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Wedbush Raises Price Target on Boston Scientific (BSX) to $25 Following 2Q
July 29, 2016 8:14 AM EDTWedbush reiterated a Neutral rating on Boston Scientific (NYSE: BSX), and raised the price target to $25.00 (from $23.00), following the company's 2Q earnings report. Total sales were $2.126 billion, and $80 million ahead of consensus, while adjusted EPS of $0.27 was in line.
Analyst Tao Levy... More
Boston Scientific (BSX) PT Raised to $28 at Needham & Company
July 28, 2016 2:38 PM EDTNeedham & Company analyst Mike Matson reiterated a Buy rating and bumped his price target on Boston Scientific (NYSE: BSX) to $28.00 (from $26.00) following doubled-digit organic growth in Q2.
Matson commented, "BSX beat consensus 2Q16 revenue and met consensus EPS. BSX's organic constant currency... More
Boston Scientific (BSX) PT Bumped to $26 at Evercore ISI
July 28, 2016 12:46 PM EDTEvercore ISI analyst Vijay Kumar reiterated a Buy rating and lifted his price target on Boston Scientific (NYSE: BSX) to $26.00 (from $25.50) following results this morning.
The firm maintained FY 2016 EPS of $1.11, FY 2017 EPS of $1.30 and raised FY 2018 EPS from $1.52 to $1.55.
Kumar commented, "Just when investors sighed a breath of relief after last Q when the long awaited new product momentum drove a... More
